Andreja Cokan Vujkovac
Overview
Explore the profile of Andreja Cokan Vujkovac including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Levstek T, Bahcic E, Vujkovac B, Cokan Vujkovac A, Tesovnik T, Remec Z, et al.
Cells
. 2025 Feb;
14(3).
PMID: 39937009
Fabry nephropathy is a life-threatening complication of Fabry disease characterized by complex and incompletely understood pathophysiological processes possibly linked to premature aging. We aimed to investigate leukocyte telomere length (LTL),...
2.
Levstek T, Vujkovac B, Cokan Vujkovac A, Trebusak Podkrajsek K
Front Med (Lausanne)
. 2023 Apr;
10:1143905.
PMID: 37035314
Introduction: Early initiation is essential for successful treatment of Fabry disease, but sensitive and noninvasive biomarkers of Fabry nephropathy are lacking. Urinary extracellular vesicles (uEVs) represent a promising source of...
3.
Vujkovac B, Kirbis I, Keber T, Cokan Vujkovac A, Tretjak M, Rados Krnel S
Clin Kidney J
. 2022 Feb;
15(2):269-277.
PMID: 35145641
Background: Fabry disease (FD) is a rare X-linked disorder of sphingolipid metabolism that results in chronic proteinuric nephropathy. Podocytes are one of the most affected renal cells and play an...
4.
Pieroni M, Moon J, Arbustini E, Barriales-Villa R, Camporeale A, Cokan Vujkovac A, et al.
J Am Coll Cardiol
. 2021 Feb;
77(7):922-936.
PMID: 33602475
Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by deficient α-galactosidase A activity that leads to an accumulation of globotriasylceramide (Gb3) in affected tissues, including the...
5.
Cokan Vujkovac A, Vujkovac B, Novakovic S, Stevanec M, Sabovic M
Angiology
. 2020 Dec;
72(5):426-433.
PMID: 33342225
Fabry disease is a rare X-linked lysosomal disorder. Alpha-galactosidase A deficiency caused by mutation leads to accumulation of glycosphingolipids predominantly in endothelial cells, leading to impairment of vascular wall morphology...
6.
Cokan Vujkovac A, Novakovic S, Vujkovac B, Stevanec M, Skerl P, Sabovic M
Nephron
. 2019 Sep;
144(1):5-13.
PMID: 31509825
Introduction: The lifespan of patients with Fabry disease (FD) is shorter than that seen in the general population. Leukocyte telomere length (LTL) and telomerase activity (TA) are potential markers of...
7.
Pleskovic A, Santl Letonja M, Cokan Vujkovac A, Makuc J, Nikolajevic Starcevic J, Petrovic D
Int Angiol
. 2017 Oct;
37(1):64-70.
PMID: 28990744
Background: Our study was designed to test a possible association between polymorphisms of the SPP1 gene (rs4754, rs28357094) and markers of carotid atherosclerosis (CIMT, number of affected segments of carotid...
8.
Keber T, Tretjak M, Cokan Vujkovac A, Mravljak M, Ravber K, Vujkovac B
Am J Case Rep
. 2017 Jun;
18:644-648.
PMID: 28596512
BACKGROUND Fabry disease is a rare and progressive X-linked inherited disorder of glycosphingolipid metabolism that is due to deficient or absent lysosomal a-galactosidase A activity. Among its other associated signs...
9.
Pleskovic A, Mankoc Ramus S, Jenko Praznikar Z, Santl Letonja M, Cokan Vujkovac A, Gazdikova K, et al.
Vasa
. 2017 Jun;
46(5):355-362.
PMID: 28593808
Background: The OPG/RANKL/RANK (osteoprotegerin/receptor-activator of nuclear factor κB ligand/receptor-activator of nuclear factor κB) axis has been recently linked to the development of atherosclerosis and plaque destabilization. We have investigated whether...
10.
Pleskovic A, Santl Letonja M, Cokan Vujkovac A, Nikolajevic Starcevic J, Caprnda M, Curilla E, et al.
Vasa
. 2017 May;
46(5):363-369.
PMID: 28521653
Background: The study was designed to test the possible association between either polymorphisms of the matrix metalloproteinase-9 (MMP-9) gene (rs17576, rs3918242) or the MMP-3 5A/6A gene polymorphism (rs3025058) with markers...